{"id":"https://openalex.org/W2090699600","doi":"https://doi.org/10.1016/j.ejphar.2011.09.277","title":"A medical food Souvenaid\u00ae for AD patients can be used safely in combination with an acetylcholinesterase inhibitor in an aged rat model","display_name":"A medical food Souvenaid\u00ae for AD patients can be used safely in combination with an acetylcholinesterase inhibitor in an aged rat model","publication_year":2011,"publication_date":"2011-09-01","ids":{"openalex":"https://openalex.org/W2090699600","doi":"https://doi.org/10.1016/j.ejphar.2011.09.277","mag":"2090699600"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejphar.2011.09.277","doi":"https://doi.org/10.1016/j.ejphar.2011.09.277","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejphar.2011.09.277","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027487091","display_name":"Nick van Wijk","orcid":"https://orcid.org/0000-0003-2272-7182","observed_orcids":["https://orcid.org/0000-0003-2272-7182"]},"institutions":[{"id":"https://openalex.org/I4210104692","display_name":"Danone (Netherlands)","ror":"https://ror.org/01c5aqt35","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210090873","https://openalex.org/I4210104692"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"N. van Wijk\u204e","raw_affiliation_strings":["Danone Research, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Danone Research, Netherlands","institution_ids":["https://openalex.org/I4210104692"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054406327","display_name":"Martijn C. de Wilde","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104692","display_name":"Danone (Netherlands)","ror":"https://ror.org/01c5aqt35","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210090873","https://openalex.org/I4210104692"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M.C. de Wilde","raw_affiliation_strings":["Danone Research, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Danone Research, Netherlands","institution_ids":["https://openalex.org/I4210104692"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001940024","display_name":"Laus M. Broersen","orcid":"https://orcid.org/0000-0002-4814-2636","observed_orcids":["https://orcid.org/0000-0002-4814-2636"]},"institutions":[{"id":"https://openalex.org/I4210104692","display_name":"Danone (Netherlands)","ror":"https://ror.org/01c5aqt35","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210090873","https://openalex.org/I4210104692"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"L.M. Broersen","raw_affiliation_strings":["Danone Research, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Danone Research, Netherlands","institution_ids":["https://openalex.org/I4210104692"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111967791","display_name":"Patrick J G H Kamphuis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]},{"id":"https://openalex.org/I4210104692","display_name":"Danone (Netherlands)","ror":"https://ror.org/01c5aqt35","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210090873","https://openalex.org/I4210104692"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"P.J. Kamphuis","raw_affiliation_strings":["Danone Research, Netherlands","Utrecht University, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Danone Research, Netherlands","institution_ids":["https://openalex.org/I4210104692"]},{"raw_affiliation_string":"Utrecht University, Netherlands","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001576822","display_name":"Jossie A. Garthoff","orcid":"https://orcid.org/0000-0003-1195-4494","observed_orcids":["https://orcid.org/0000-0003-1195-4494"]},"institutions":[{"id":"https://openalex.org/I4210104692","display_name":"Danone (Netherlands)","ror":"https://ror.org/01c5aqt35","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210090873","https://openalex.org/I4210104692"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"J.A. Garthoff","raw_affiliation_strings":["Danone Research, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Danone Research, Netherlands","institution_ids":["https://openalex.org/I4210104692"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064654759","display_name":"Gerrit J. A. Speijers","orcid":"https://orcid.org/0000-0003-0210-7162","observed_orcids":["https://orcid.org/0000-0003-0210-7162"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G.J.A. Speijers","raw_affiliation_strings":["GETS, General-Health Effects Toxicity Safety Food, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GETS, General-Health Effects Toxicity Safety Food, Netherlands","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5027487091"],"corresponding_institution_ids":["https://openalex.org/I4210104692"],"apc_list":{"value":3230,"currency":"USD","value_usd":3230},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.16301309,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"668","issue":null,"first_page":"e36","last_page":"e36"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.6996999979019165,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.6996999979019165,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.27219998836517334,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.013100000098347664,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/souvenaid","display_name":"Souvenaid","score":0.8740000128746033},{"id":"https://openalex.org/keywords/medical-foods","display_name":"medical foods","score":0.7919999957084656},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9739999771118164},{"id":"https://openalex.org/keywords/acetylcholinesterase-inhibitors","display_name":"acetylcholinesterase inhibitors","score":0.9850000143051147},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7009999752044678},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6840000152587891},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.47699999809265137}],"concepts":[{"id":"https://openalex.org/C2778816929","wikidata":"https://www.wikidata.org/wiki/Q22676679","display_name":"Acetylcholinesterase","level":3,"score":0.7810988426208496},{"id":"https://openalex.org/C2777544248","wikidata":"https://www.wikidata.org/wiki/Q2592323","display_name":"Acetylcholinesterase inhibitor","level":4,"score":0.5723633170127869},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.48132264614105225},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4327126741409302},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2763368487358093},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.18238767981529236},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17424005270004272}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.ejphar.2011.09.277","doi":"https://doi.org/10.1016/j.ejphar.2011.09.277","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejphar.2011.09.277","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4234133592","https://openalex.org/W2054296326","https://openalex.org/W4316035935","https://openalex.org/W3133561357","https://openalex.org/W4238047130","https://openalex.org/W2094088894","https://openalex.org/W1991014252","https://openalex.org/W2953458619","https://openalex.org/W2417561987","https://openalex.org/W4251946790"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}